MedPath

Optical Angiography in Glaucoma

Completed
Conditions
Glaucoma
Interventions
Device: Optical angiography based on OCT
Registration Number
NCT02548676
Lead Sponsor
Medical University of Vienna
Brief Summary

Glaucoma is one of the leading causes for blindness in industrialized countries. It is characterized by a progressive loss of retinal ganglion cells, morphological changes in the optic nerve head and a characteristic loss of visual field. It has been speculated for a long time that vascular factors may also contribute to the pathogenesis of the disease. This concept has been supported by several epidemiological studies showing that small retinal vessel calibre are associated with the disease. In the recent years tremendous enhancements in the field of optical coherence tomography has been achieved. These developments made it possible to visualize the retinal vasculature in a full depth manner without the application of an intravenous marker. The proposed study tests the hypothesis that patients with glaucoma show altered vascular morphology compared to healthy subjects. This is of importance because it may clarify the degree of vascular involvement in glaucoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Diagnosis of manifest open angle glaucoma as defined as pathological optic disc appearance, glaucoma hemifield test outside normal limits and/or untreated IOP ≥ 21 mmHg on at least three measurements in the medical history. Mean deviation in the visual field test < 10dB
Read More
Exclusion Criteria
  • Normal ophthalmic findings, IOP ≤ 20mmHg
  • No history of elevated IOP
  • No signs of glaucomatous disc damage
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Glaucoma PatientsOptical angiography based on OCTPatients with primary open angle glaucoma
Healthy controlsOptical angiography based on OCTage- and sex matched controls
Primary Outcome Measures
NameTimeMethod
Retinal vessel diameter as extracted from the angiogramsduring the four weeks after the first screening day
Secondary Outcome Measures
NameTimeMethod
Systemic hemodynamics (Blood pressure)during the four weeks after the first screening day
Intraocular pressureduring the four weeks after the first screening day
pulseduring the four weeks after the first screening day

Trial Locations

Locations (1)

Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath